Advertisement

3D printers that work with biomedical materials are poised to transform healthcare, paving the way for technologies such as personalized stents, on-demand transplantable organs and cheap prosthetics.

New 3D printing technology has captured imaginations from NASA labs to art studios, but so-called "bio-printing" may be the revolution with the greatest direct human impact.

San Diego, Calif.-based Organovo Holdings' bio-printer is making its start in 3D-printed diagnostic assays, but the future holds much bigger things. Organovo's assays allow pharmaceutical companies to more thoroughly test liver toxicity, possibly avoiding costly delays or failures in new drug development, but those liver assays are a pathway to full-organ printing of the liver as well as other organs, Daily Finance reported.

Advertisement
Advertisement